The Top Cannabis Stocks with a Powerful Colombian Market Catalyst

With favorable cannabis-growing conditions, Colombia is quickly emerging as an industry hot spot. In fact, the country could capture as much as a fifth of a global market that could be worth $40 billion a year, according to Reuters.

“Colombia is wooing foreign investors, talking up its potential in the new era of peace as a resource-rich country with a business-friendly regulatory environment,” noted The Globe and Mail. “Colombia has the ideal climate for cannabis, with the evenly split 12 hours of light and dark each day that the plant prefers, a pool of low-cost labor and easily-transferable expertise and infrastructure from a large cut-flower export business.”

That could be quite beneficial to several cannabis stocks with exposure including Blueberries Medical Corp. (CSE:BBM)(OTC:BBRRF), Khiron Life Sciences Corporation (OTC:KHRNF) (TSXV:KHRN), and PharmaCielo Ltd. (OTC:PHCEF)(TSXV:PCLO).

Colombian-based producer, Blueberries Medical Corp (BBM), for example, just announced its common shares are now listed on the Frankfurt Stock Exchange (FSE) trading under the ticker symbol “1OA”. The stock will also continue to list on the Canadian Stock Exchange and on the OTC in the United States.

“Listing on the Frankfurt Stock Exchange is an important milestone for Blueberries, consistent with our global strategy which includes exports to the European market,” stated Camilo Villalba, Chief Operating Officer. “It will allow us to broaden our shareholder base to include more investors based in Europe as cannabis markets continue to expand globally.”

The company also just entered into a letter of intent for a joint venture with India Colorada S.A.S., a leading Colombian brewer and producer of Cerveza Colón, to research, develop and commercialize non-alcoholic cannabis-based beverages. "As consumer preferences continue to evolve away from smoked flower and towards healthier and more convenient products, we plan to be on the leading edge of innovating and commercializing these new product segments,” stated Camilo Villalba, BBM COO, noted.

For More Information on Blueberries Medical Corp., Click Here.

Analysts at Canaccord Genuity raised their price target on Khiron Life Sciences Corporation (KHRN)(KHRNF) to C$6.50 a share. “In our view, the company has a significant number of potential catalysts that should keep share price momentum going. Commercial sales of medical CBD products are expected in the early part of Q2, while a generous commercial THC quote toward mid-year could further validate Khiron’s distribution strategy,” the analysts noted.

“The passing of Mexican medical and recreational cannabis laws (likely in Q2) are also significant potential catalysts and we note that the company is co-hosting a large cannabis conference, CannaMexico, April 25-26.”

For More Information on Khiron Life Sciences Corporation, Click Here.

Analysts at GMP just initiated coverage on PharmaCielo Ltd. (PHCEF)(PCLO) with a Buy rating and a price target of C$12. They also note that PCLO is the best pure-play on the global CDB market. “We consider PCLO to be the most advanced Colombian licensed producer currently, providing a ~6–18 month first-mover advantage over nearly all Colombian competitors. In addition, with CBD extract capacity expected to reach ~17 tonnes in 2019, we believe this qualifies PCLO as the largest international publicly-traded producer.”

“With favorable Colombian regulations, we estimate PCLO could have CBD yields ~250x–300x higher than those available to global peers. We believe PCLO could achieve CBD extract production costs as low as ~$0.15–0.25/gram, potentially the lowest globally.”

For More Information on PharmaCielo Ltd., Click Here. is a leading web destination for all cannabis related companies. Investors can also find current marijuana-related quality financial, medical, legal and social news. is a media agency in North America dedicated to the cannabis industry, helping companies that operate in the space to attract quality investors, working capital and real publicity. Since 2005, we have had public companies in the US and Canada have rely on us to grow and succeed.

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Winning Media which has a partnership with is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.

For making specific investment decisions, readers should seek their own advice. Winning Media, which has a partnership with, is only compensated for its services in the form of cash-based compensation. Pursuant to an agreement between Winning Media (partners of and Blueberries Medical Corp. Winning Media has been paid four thousand dollars for advertising and marketing services for Blueberries Medical Corp. We own ZERO shares of Blueberries Medical Corp. Please click here for full disclaimer.

Contact Information:
[email protected]